Isolation of plasma small-dense low-density lipoprotein using a simple air-driven ultracentrifuge and quantification using immunoassay of apolipoprotein B

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 1, 2004, Pages 30-36

  Menys, Valentine C ^a   Lui, Yifen ^a   Mackness, Michael I ^a   Kwok, See ^b   Caslake, Muriel J ^c   Stewart, Grace ^c   Durrington, Paul N ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b Barlow Medical Centre   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Coronary heart disease; Dyslipidaemia; HDL cholesterol; Small dense LDL; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; QUANTITATIVE ASSAY; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION;

APOLIPOPROTEINS B; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERLIPIDEMIAS; IMMUNOASSAY; LIPOPROTEINS, LDL; MALE; REPRODUCIBILITY OF RESULTS; TRIGLYCERIDES; ULTRACENTRIFUGATION;

EID: 1642566151     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.007     Document Type: Article

References (28)

1. Havel RJ, Eder HA, Bragden JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
2. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoprotein in normal humans. J Lipid Res 1982;23:97-104.
3. Chapman MJ, Laplaud PM, Luc G, Forgez P, Bruckert E, Goulinet S, et al. Further resolution of the low density lipoprotein spectrum in normal human plasma: Physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res 1988;29:442-58.
4. Krauss RM, Blanche PJ. Detection and quantitation of LDL subfractions. Curr Opin Lipidol 1992;3:377-83.
5. Musliner TA, Krauss RM. Lipoprotein subspecies and risk of coronary disease. Clin Chem 1988;34:B78-B83.
6. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988;26:1917-21.
7. Griffin BA, Freeman DJ, Tait GW, Thompson J, Caslake MJ, Packard CJ, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994;106:241-51
8. Rajman I, Kendall MJ, Cramb R, Holder RL, Gammage MD. Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis 1996;125:231-42.
9. Karpe F, Hamsten A. Determination of apolipoprotein B-48 and B-100 in triglyceride-rich lipoprotein by analytical SDS-PAGE. J Lipid Res 1994;35:1311-7.
10. Koglund-Andersson C, Tang R, Bond MG, de Faire U, Hamsten A, Karpe F. LDL particle size distribution is associated with intima-media thickness in healthy 50 year-old men. Arterioscler Thromb Vasc Biol 1999;19:2422-30.
11. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J. Rapid isolation of low density (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 1990;83:59-67.
12. Reaven PD, Grasse BJ, Tribble DL. Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler Thromb 1994;14:557-66.
13. Wallace AJ, Humphries SE, Fisher RM, Mann JI, Chisholm A, Sutherland WHF. Genetic factors associated with response of LDL subfractions to change in the nature of dietary fat. Atherosclerosis 2000;149:387-94.
14. Bakogianni MC, Kalofoutis CA, Skenderi KI, Kalofoutis AT. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease. J Diabetes Complications 2001;15:265-9.
15. Sweetnam PM, Bolton CH, Yarnell JW, Bainton D, Baker IA, Elwood PC, et al. Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation 1994;90:769-74.
16. Rosseneu M, Vinaimont N, Vercaemst R, Van Biervliet JP. Separation of lipoproteins in newborn plasma using an Airfuge ultracentrifuge. Artery 1982;11:145-55.
17. Menys VC, Lui Y, Mackness MI, Caslake MJ, Kwok S, Durrington PN. Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B. Clin Chim Acta 2003;334:95-106.
18. Mackness MI, Durrington PN. Lipoprotein separation and analysis for clinical studies. In: Skinner ER, Converse CA, editors. Lipoprotein analysis. A practical approach. Oxford: Oxford University Press, 1992:1-42.
19. 3. Clin Chim Acta 1981;114:225-31.
20. Jones R, Payne B. Clinical investigation and statistics in laboratory medicine. In: McCreanor G, Sherwood RA, editors. Management and technology in laboratory medicine series. London: ABC Venture Publications, 1997.
21. Scheffer PG, Bakkar SJL, Heine RJ, Teerlink T. Measurement of low-density lipoprotein particle size by high-performance gel-filtration chromatography. Clin Chem 1997;43:1904-12.
22. Otvos JD, Shalaurova I, Freedman DS, Rosenson RS. Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-1 trial. Atherosclerosis 2002;160:41-8.
23. Kulkarni KR, Markovitz JH, Nanda NC, Segrest JP. Increased prevalence of smaller and denser LDL particles in Asian Indians. Arterioscler Thromb Vasc Biol 1999;19:2749-55.
24. Bittolo-Bon G, Cazzalato G. Analytical capillary isotachophoresis of total plasma lipoproteins: A new tool to identify atherogenic low density lipoproteins. J Lipid Res 1999;40:170-7.
25. Nguyen C, Charles MA. Atherogenic lipid phenotype and lipoprotein (a) in diabetes. The Endocrinologist 2002;12:246-59.
26. Lamarche B, Lemieux I, Després JP. The small, dense LDL phenotype and the risk of coronary artery disease: Epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab 1999;25:199-211.
27. McNamara JR, Jenner JL, Li Z, Wilson PWF, Schaefer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 1992;12:1284-90.
28. Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, et al. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apo B-containing lipoprotein subclasses (VLDL-2, IDL, small-dense LDL) and stimulation of cellular cholesterol efflux. Atherosclerosis 2002;163:287-96.